Holy Hormones Journal:We need to treat the body as a whole. If cancer is present in one organ – it does not mean take out – or cut off the organ/body part and the cancer issue is resolved. Chemo and radiation destroy what the body needs to rid itself of cancer.
From a whole health and woman’s perspective, one would look at the imbalance – where the origin might be and then right the wrong – in other words heal the imbalance… In many cases that can be done with detoxification and nutritional supplementation. Getting rid of the toxins is crucial. Then giving your body the nutrition it needs to heal itself should be the primary treatment. But do not wait until you have a diagnosis. Protect yourself now.
Thyroid Cancer Risk Increased After Breast Cancer
March 13, 2015
SAN DIEGO — The risk for developing thyroid cancer appears to be higher in breast cancer survivors, especially among those aged younger than 50 years with invasive ductal carcinoma, new data presented at ENDO 2015 suggest.
“Although the incidence of breast cancer has been somewhat stable over the last couple of decades, it is still a leading cause of cancer and affects 1 in 8 women in this country sometime in their lifetime,” study researcher Jennifer Kuo, MD, assistant professor of surgery at Columbia University in New York City, said during a press conference.
This means, she noted, that the number of breast cancer survivors has increased substantially. However, these survivors have an 18% to 30% increased risk for developing a second cancer. Although these second cancers are usually hormonally mediated, such as ovarian or uterine cancers, some studies have suggested that incidence of thyroid cancer is also increased in this patient population.
To investigate the potential relationship between breast cancer and second primary thyroid cancer, Dr. Kuo conducted a retrospective cohort analysis of the Surveillance, Epidemiology, and End Results (SEER)-9 database. Specifically, she looked at the years from 1973 to 2011.
Dr. Kuo identified more than 700,000 patients with breast cancer and just under 50,000 with thyroid cancer. She then cross-referenced these two patient cohorts and found about 1,500 patients who developed thyroid cancer after breast cancer. Patients who had breast cancer only and those who had thyroid cancer only were then compared.
Dr. Kuo calculated age-specific 10-year risk for developing thyroid cancer after breast cancer and compared it with the age-specific 10-year risk published by the SEER database.
Results indicated that median time to development of second primary thyroid cancer was 5 years. When compared with patients who had breast cancer only, those who developed thyroid cancer after breast cancer were younger when they received their breast cancer diagnosis (aged 50 years or younger); had smaller tumors; and had a greater percentage of invasive ductal carcinoma.